Quantum-Si incorporated

NasdaqGM:QSI Stock Report

Market Cap: US$202.6m

Quantum-Si Management

Management criteria checks 3/4

Quantum-Si's CEO is Jeff Hawkins, appointed in Oct 2022, has a tenure of 3.75 years. total yearly compensation is $3.18M, comprised of 19.5% salary and 80.5% bonuses, including company stock and options. directly owns 0.32% of the company’s shares, worth $648.41K. The average tenure of the management team and the board of directors is 3.5 years and 3.2 years respectively.

Key information

Jeff Hawkins

Chief executive officer

US$3.2m

Total compensation

CEO salary percentage19.50%
CEO tenure3.8yrs
CEO ownership0.3%
Management average tenure3.5yrs
Board average tenure3.2yrs

Recent management updates

Recent updates

Narrative Update Jun 26

QSI: Partnership Progress Will Support Future Single Molecule Sequencing Adoption

Analysts have cut their price target for Quantum-Si, citing updated assumptions that reflect a fair value of $1.00, a higher discount rate of 7.91%, much stronger modeled revenue growth of 138.19%, a slightly adjusted profit margin of 15.57%, and a reduced future P/E of 85.78x. What’s in the News for Quantum-Si Quantum-Si announced a partnership with Cell Signaling Technology to combine post-translational modification detection and immunoaffinity enrichment expertise with Quantum-Si’s Proteus single-molecule protein sequencing workflows for research use.
Analysis Article May 07

Here's Why We're Watching Quantum-Si's (NASDAQ:QSI) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Analysis Article Dec 13

Is Quantum-Si (NASDAQ:QSI) In A Good Position To Invest In Growth?

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Seeking Alpha Oct 27

Quantum-Si: Critical 12 Months Ahead

Summary Quantum-Si's fundamentals are weak at the moment, and this likely extends beyond market conditions. This hasn't mattered to the stock, as Quantum-Si's share price is being driven more by sentiment and quantum hype than financial performance. The Proteus system could alter the trajectory of the business, but technology risk is high and there is competition. While I am negative on QSI's prospects, shorting the stock is risky given the company's cash balance, potential positive news on Proteus and rebounding biopharma demand. Read the full article on Seeking Alpha
Analysis Article Jun 26

We're Hopeful That Quantum-Si (NASDAQ:QSI) Will Use Its Cash Wisely

We can readily understand why investors are attracted to unprofitable companies. By way of example, Quantum-Si...
Seeking Alpha Mar 11

Quantum-Si: A Rose, By Any Other Name, Wouldn't Smell As Sweet

Summary Quantum-Si aims to revolutionize protein sequencing but faces significant technological and competitive challenges. Commercial reception to Quantum-Si's solutions has been lukewarm so far, suggesting a significant improvement in performance will be needed to drive wider adoption. Quantum-Si believes that it can introduce a superior system in the next few years, but this involves significant uncertainty. The recent surge in Quantum-Si's share price appears to have been driven more by quantum computing hype than the fundamentals of its business. Read the full article on Seeking Alpha
Seeking Alpha Jan 04

Quantum-Si: Another Wrong Horse On The Quantum Computing Racetrack - Sell

Summary Similar to data storage solutions provider Quantum Corporation, life sciences company Quantum-Si appears to be have been picked as a quantum computing play solely due to its name. Since listing on Nasdaq in a backdoor IPO almost four years ago, the company has burned almost $350 million in cash and remains way behind its original business plan. However, Quantum-Si has managed to capitalize on the hype by raising additional funds, thus extending its cash runway by more than one year to late 2027. With the company not involved in quantum computing, I would expect momentum traders to leave for assumed greener pastures sooner rather than later. As a result, I am initiating Quantum-Si's common stock with a "Sell" rating. Read the full article on Seeking Alpha
Seeking Alpha Dec 29

Quantum-Si Isn't A Quantum Computing Company, And Shares Are Overvalued

Summary Quantum-Si has seemingly surged as part of the quantum computing trend, but its own operating business is not focused on quantum computing. Quantum-Si has badly missed its initial SPAC projections and is struggling to gain commercial momentum. Quantum-Si's balance sheet is healthy for now, but it will likely need more cash by the end of 2026 to commercialize its Platinum platform. Given the unproven business model and potential for a secondary offering, traders would be wise to exit positions now. Read the full article on Seeking Alpha
Seeking Alpha Dec 16

Quantum-Si: Lack Of Commercial Traction Despite Product Upgrades

Summary Quantum-Si (QSI) has made significant progress in technology and management but missed revenue forecasts for 2024, leading to a revised hold rating. Key partnerships with Nvidia, Planet Innovations, and SkyWater aim to enhance product capabilities, particularly with the upcoming Proteus platform. Despite promising advancements, QSI's commercial traction remains insufficient, delaying profitability and necessitating potential capital raises within two years. The product development roadmap is strong, but substantial revenue growth is crucial for QSI to achieve long-term success and profitability. Read the full article on Seeking Alpha
Seeking Alpha Nov 26

Quantum-Si Is Too Speculative For Me (Technical Analysis)

Summary Quantum-Si has shown bullish price action recently, but I remain skeptical due to its history of bearish trends and potential for a pullback. Short-term momentum is bullish on Quantum-Si stock, but long-term momentum remains bearish, as indicated by the Percentage Price Oscillator (PPO) readings. Volume activity is highly bullish, showing significant institutional interest, yet relative strength remains bearish compared to the S&P 500 index. I recommend waiting for QSI stock to stabilize below the 30-week EMA without making new lows, then reassessing for long-term bullish momentum and institutional buying. Read the full article on Seeking Alpha
Analysis Article Nov 06

Is Quantum-Si (NASDAQ:QSI) In A Good Position To Deliver On Growth Plans?

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analysis Article Aug 03

Here's Why We're Watching Quantum-Si's (NASDAQ:QSI) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, although...
Analysis Article Apr 19

Quantum-Si (NASDAQ:QSI) Is In A Good Position To Deliver On Growth Plans

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
Seeking Alpha Feb 05

Quantum-Si: Commercial Lift Imminent

Summary Quantum-Si is about to move from a controlled launch to a full scale commercial launch of its first product. It will be a groundbreaking device, a desktop Proteome sequencer at a fraction of the price of competing technology. If the product is successful, QSI stock is likely significantly undervalued. Read the full article on Seeking Alpha
Analysis Article Dec 04

Companies Like Quantum-Si (NASDAQ:QSI) Are In A Position To Invest In Growth

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analysis Article Jun 28

We Think Quantum-Si (NASDAQ:QSI) Can Afford To Drive Business Growth

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Seeking Alpha Oct 04

Jeff Hawkins is the new CEO of Quantum-Si

Quantum-Si (NASDAQ:QSI) appoints veteran life sciences executive Jeff Hawkins as Chief Executive Officer effective October 10, 2022, succeeding Dr. Jonathan Rothberg, Interim Chief Executive Officer, Founder and Executive Chairman. Most recently Jeff Hawkins was President and Chief Executive Officer of Truvian Sciences.

CEO Compensation Analysis

How has Jeff Hawkins's remuneration changed compared to Quantum-Si's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2026n/an/a

-US$104m

Dec 31 2025US$3mUS$621k

-US$101m

Sep 30 2025n/an/a

-US$117m

Jun 30 2025n/an/a

-US$106m

Mar 31 2025n/an/a

-US$101m

Dec 31 2024US$4mUS$596k

-US$101m

Sep 30 2024n/an/a

-US$90m

Jun 30 2024n/an/a

-US$89m

Mar 31 2024n/an/a

-US$92m

Dec 31 2023US$1mUS$575k

-US$96m

Sep 30 2023n/an/a

-US$107m

Jun 30 2023n/an/a

-US$114m

Mar 31 2023n/an/a

-US$121m

Dec 31 2022US$8mUS$132k

-US$132m

Compensation vs Market: Jeff's total compensation ($USD3.18M) is above average for companies of similar size in the US market ($USD1.64M).

Compensation vs Earnings: Jeff's compensation has been consistent with company performance over the past year.


CEO

Jeff Hawkins (48 yo)

3.8yrs
Tenure
US$3,183,693
Compensation

Mr. Jeffrey Alan Hawkins, also known as Jeff, serves as Chief Executive Officer at Quantum-Si incorporated since joining from October 10, 2022 and serves as its Director since October 2022 also serves as i...


Leadership Team

NamePositionTenureCompensationOwnership
Jeffrey Hawkins
President3.8yrsUS$3.18m0.32%
$ 648.4k
Jonathan Rothberg
Founder & Executive Directorno dataUS$195.00k15.45%
$ 31.3m
Jeffry Keyes
CFO & Treasurer3.2yrsUS$1.66m0.16%
$ 332.5k
John Vieceli
Chief Product Officer1.9yrsUS$1.46m0.099%
$ 200.2k
Todd Rearick
Chief Technology Officer7.5yrsno datano data
Christian Lapointe
General Counsel & Corporate Secretary5.7yrsUS$2.07m0.24%
$ 488.2k
Lindsay Thompson
Chief Human Resources Officer1.9yrsno datano data
3.5yrs
Average Tenure
53yo
Average Age

Experienced Management: QSI's management team is considered experienced (3.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Jeffrey Hawkins
President3.8yrsUS$3.18m0.32%
$ 648.4k
Jonathan Rothberg
Founder & Executive Directorno dataUS$195.00k15.45%
$ 31.3m
Kevin Rakin
Independent Director6.1yrsUS$203.13k0.0094%
$ 19.1k
Brigid Makes
Independent Director5.1yrsUS$208.75k0.0094%
$ 19.1k
Ruth Fattori
Independent Director5.3yrsUS$213.75k0.078%
$ 158.6k
Charles Kummeth
Independent Chairman2.2yrsUS$245.00k0.39%
$ 795.5k
Scott Mendel
Independent Director3.2yrsUS$211.25k0.065%
$ 132.0k
Amir Jafri
Independent Director2.8yrsUS$207.50k0.053%
$ 107.9k
Paula Dowdy
Independent Director2.3yrsUS$202.81k0.12%
$ 250.4k
John Kenny
Independent Director3.2yrsUS$212.50k0.052%
$ 106.3k
Gloria Sheynkman
Chair of the Scientific Advisory Board1.4yrsno datano data
Benjamin Garcia
Member of the Scientific Advisory Board1.4yrsno datano data
3.2yrs
Average Tenure
61.5yo
Average Age

Experienced Board: QSI's board of directors are considered experienced (3.2 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/05 00:33
End of Day Share Price 2026/07/02 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Quantum-Si incorporated is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Scott HenryAlliance Global Partners
Kyle MiksonCanaccord Genuity
Swayampakula RamakanthH.C. Wainwright & Co.